Cogent Biosciences, Inc.

COGT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q Nov 7, 2025 10-Q
8-K Nov 3, 2025 8-K
4 Oct 3, 2025 4
8-K Sep 11, 2025 8-K
SCHEDULE 13G/A Aug 14, 2025
SCHEDULE 13G Aug 14, 2025
SCHEDULE 13G/A Aug 14, 2025
SCHEDULE 13G/A Aug 14, 2025
10-Q Aug 5, 2025 10-Q
8-K Aug 5, 2025 8-K
SCHEDULE 13D/A Jul 14, 2025
4 Jul 14, 2025 OWNERSHIP DOCUMENT
SCHEDULE 13G Jul 11, 2025
8-K Jul 10, 2025 8-K
424B5 Jul 9, 2025 424B5
424B5 Jul 8, 2025 424B5
8-K Jul 7, 2025 8-K
4 Jul 2, 2025 4
8-K Jun 11, 2025 8-K
4 Jun 5, 2025 4
4 Jun 5, 2025 4
4 Jun 5, 2025 4
4 Jun 5, 2025 4
4 Jun 5, 2025 4
4 Jun 5, 2025 4
← Newer Page 4 of 25 · 616 filings Older →